Package 0517-0955-01

{"route": ["INTRAMUSCULAR"], "spl_id": "ad82611b-9883-4583-95bd-17a021346db5", "openfda": {"nui": ["N0000175430"], "unii": ["N7U69T4SZR"], "rxcui": ["485968"], "spl_set_id": ["e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["American Regent, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (0517-0955-01)  / 2 mL in 1 VIAL, GLASS", "package_ndc": "0517-0955-01", "marketing_start_date": "20120627"}], "brand_name": "Olanzapine", "product_id": "0517-0955_ad82611b-9883-4583-95bd-17a021346db5", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "0517-0955", "generic_name": "Olanzapine", "labeler_name": "American Regent, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/2mL"}], "application_number": "ANDA201741", "marketing_category": "ANDA", "marketing_start_date": "20120627", "listing_expiration_date": "20261231"}